Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

GSK plc (GSK) Form 6-K — Sep 10, 2026

$GSKForm 6-KFiled Sep 10, 2026, 10:31 AM ET0001654954-26-008255Original filing

GSK plc filed a Form 6-K disclosing a manager-dealing notification under its PDMR/PCA procedures involving Maya Martinez-Davis, President, US. On September 8, 2026, she acquired 9.837 notional American Depositary Shares at $48.5400 each on the New York Stock Exchange. The acquisition was made within her GSK Executive Supplemental Savings Plan account, meaning the shares were booked notionally as part of executive compensation rather than through an open-market purchase.

Key figures

Venue
New York Stock Exchange (XNYS)
Instrument
American Depositary Shares (ADS), ISIN US37733W2044
Ads acquired
9.837
Transaction date
2026-09-08
Transaction nature
Acquisition of notional ADS within GSK Executive Supplemental Savings Plan account
Transaction price usd per ads
48.54

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    GSK plc (GSK) Form 6-K — Sep 10, 2026: AI Analysis | Signal8